- Same Thing
- Side Effects
- What Is
- Drug Interactions
Are Wixela Inhub and Nucala the Same Thing?
Wixela Inhub is used for twice-daily treatment of asthma in patients aged 4 years and older and also for maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD).
Nucala is used for add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.
Wixela Inhub and Nucala belong to different drug classes. Wixela Inhub contains a combination of a corticosteroid and a long-acting beta-adrenergic agonist (LABA) and Nucala is an interleukin-5 antagonist monoclonal antibody (IgG1 kappa).
Side effects of Wixela Inhub and Nucala that are similar include headaches.
Side effects of Wixela Inhub that are different from Nucala include upper respiratory tract infection or inflammation, sore throat, hoarseness, oral thrush, bronchitis, cough, nausea, vomiting, pneumonia, and musculoskeletal pain.
Side effects of Nucala that are different from Wixela Inhub include injection site reactions, back pain, fatigue, flu symptoms, urinary tract infection (UTI), abdominal pain, itching, eczema, and muscle spasms.
Wixela Inhub may interact with other medicines containing a LABA, antivirals, azole antifungals, clarithromycin, telithromycin, nefazodone, monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, beta-blockers, and diuretics.
Nucala may also interact with other drugs.
What Are Possible Side Effects of Wixela Inhub?
Common side effects of Wixela Inhub include:
What Are Possible Side Effects of Nucala?
Common side effects of Nucala include:
What Is Wixela Inhub?
Wixela Inhub (fluticasone propionate and salmeterol inhalation powder) contains a combination of a corticosteroid and a long-acting beta-adrenergic agonist (LABA) indicated for twice-daily treatment of asthma in patients aged 4 years and older or maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD). Wixela Inhub is available in generic form.
What Is Nucala?
Nucala (mepolizumab) is an interleukin-5 (IL-5) antagonist monoclonal antibody (IgG1 kappa) indicated for add-on maintenance treatment of patients with severe asthma aged 6 years and older, and with an eosinophilic phenotype; the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA); and the treatment of adult and pediatric patients aged 12 years and older with hypereosinophilic syndrome (HES) for 6 or more months without an identifiable non-hematologic secondary cause.
What Drugs Interact With Wixela Inhub?
Wixela Inhub may interact with additional medicines containing a LABA, ritonavir, ketoconazole, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir, telithromycin, monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, beta-blockers, and diuretics. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using Wixela Inhub; it is unknown how it would affect a fetus. It is unknown if Wixela Inhub passes into breast milk. Consult your doctor before breastfeeding.
How Should Wixela Inhub Be Taken?
The dose of Wixela Inhub for treatment of asthma in patients aged 12 years and older is 1 inhalation of Wixela Inhub 100/50, Wixela Inhub 250/50, or Wixela Inhub 500/50 twice daily. The dose of Wixela Inhub for treatment of asthma in patients aged 4 to 11 years is 1 inhalation of Wixela Inhub 100/50 twice daily. The dose of Wixela Inhub for maintenance treatment of COPD is 1 inhalation of Wixela Inhub 250/50 twice daily.
How Should Nucala Be Taken?
The dose of Nucala is 100 mg administered subcutaneously once every 4 weeks. Nucala may interact with other drugs. Tell your doctor all medications and supplements you use.
Asthma and Allergy Resources
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.
GSK. Nucala Product Information.